compounded glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Compound versions of GLP-1 drugs
Description
doi: 10.1016/j.diabres.2024.111675, 3
Oral antidiabetic medication was discontinued 3 weeks prior to the study
As she recalls, 'I remember feeling a little bit scared
We do not know the answer to this question
And the numbers are eye-opening
doi:10.1016/j.bbrc.2019.04.160 55
